400
Participants
Start Date
July 26, 2022
Primary Completion Date
November 7, 2023
Study Completion Date
November 14, 2023
HSK3486
HSK3486 for induction of general anesthesia
Propofol
Propofol for induction of general anesthesia.
Chesapeake Research Group, Llc, Pasadena
Duke University Health, Durham
Coastal Clinical Research Specialists, Jacksonville
University of Miami Hospital, Miami
Phoenix Clinical Research, Tamarac
ForCare Clinical Research, Tampa
Gulfcoast Research Institute, Llc, Sarasota
Shoals Medical Trials, Inc., Sheffield
The Ohio State University Wexner Medical Center, Columbus
University Hospitals Cleveland Medical Center, Cleveland
Midwest Clinical Research Center, Dayton
Rush University Medical Center, Chicago
NextStage Clinical Research - Abay Neuroscience Center, Wichita
Hd Research Llc., Carrollton
The University of Texas - MD Anderson Cancer Center, Houston
HD Research, Bellaire
Urology San Antonio Research, San Antonio
Endeavor Clinical Trials, San Antonio
Jbr Clinical Research, Salt Lake City
Arizona Research Center, Phoenix
UC Davis Health, Davis
Oregon Health & Science University, Portland
Brigham & Women'S Hospital, Boston
Lead Sponsor
Haisco-USA Pharmaceuticals, Inc.
INDUSTRY